Literature DB >> 31149149

LONGER CECUM INSERTION TIME AND MORE INADEQUATE COLONIC PREPARATION IN PATIENTS WITH ACROMEGALY: IS A DIFFERENT COLONOSCOPY PREPARATION NEEDED?

E Caglar1, E Hatipoglu2, D Atasoy3, M Niyazoglu2, A S Çağlar4, M Tuncer5, A Dobrucali5, P Kadioglu2.   

Abstract

PURPOSE: To investigate whether there is a difference between acromegalic and non-acromegalic cases in terms of bowel preparation and colonoscopic intervention.
METHODS: Patients with controlled and uncontrolled acromegaly and as a control group (CG) patients without acromegaly between January 2010 and March 2014 were included. Groups were compared regarding adequacy of bowel preparation, cecal insertion time (CIT) and colonoscopy results.
RESULTS: Fifty-nine patients with acromegaly (controlled n=30, uncontrolled n=29) and 73 age and gender matched volunteers without acromegaly were evaluated. CIT in cases with controlled, uncontrolled acromegaly cases and in CG was 5.33 [4.00-6.00], 7.00 [4.91-11.31], and 3.10 [2.35-4.65] minutes, respectively (p<0.001). Cases in CG had shorter CIT compared to controlled and uncontrolled acromegaly cases ( p=0.014 and p<0.001, respectively). There was no significant difference regarding CIT between controlled and uncontrolled acromegaly cases (p=0.247). Six (20%) of controlled acromegaly patients, 10 (35%) of uncontrolled acromegaly patients and three (4%) of CG had inadequate bowel cleansing (p<0.001). Although statistically insignificant, cases with inadequate bowel cleansing had tendency towards having prolonged CIT in comparison to cases with adequate bowel cleansing (6.00 [3.87-9.00] and 4.16 [2.95-5.70] minutes, respectively, p=0.07).
CONCLUSION: Inadequate bowel cleansing is one of the main problems encountered during colonoscopic investigation/surveillance in acromegalic patients. Therefore, a different protocol for colonoscopy preparation may be needed for these cases.

Entities:  

Keywords:  Acromegaly; cecal insertion time; colon cleansing; colonoscopy; colonoscopy preparation

Year:  2017        PMID: 31149149      PMCID: PMC6525746          DOI: 10.4183/aeb.2017.60

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  24 in total

Review 1.  Acromegaly and cancer: not a problem?

Authors:  S Melmed
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

Review 2.  Clinical perspective: acromegaly and cancer: a problem.

Authors:  P J Jenkins; M Besser
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

3.  Colorectal neoplasia in acromegaly.

Authors:  P J Jenkins; P D Fairclough
Journal:  Clin Endocrinol (Oxf)       Date:  2001-12       Impact factor: 3.478

4.  The prevalence and characteristics of colorectal neoplasia in acromegaly.

Authors:  A G Renehan; P Bhaskar; J E Painter; S T O'Dwyer; N Haboubi; J Varma; S G Ball; S M Shalet
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

5.  Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.

Authors:  M J Veysey; L A Thomas; A I Mallet; P J Jenkins; G M Besser; J A Wass; G M Murphy; R H Dowling
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

6.  A prospective study of factors that determine cecal intubation time at colonoscopy.

Authors:  Crystal Bernstein; Michael Thorn; Kelly Monsees; Rhonda Spell; J Barry O'Connor
Journal:  Gastrointest Endosc       Date:  2005-01       Impact factor: 9.427

7.  Factors affecting insertion time and patient discomfort during colonoscopy.

Authors:  W H Kim; Y J Cho; J Y Park; P K Min; J K Kang; I S Park
Journal:  Gastrointest Endosc       Date:  2000-11       Impact factor: 9.427

8.  A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda.

Authors:  C A Aronchick; W H Lipshutz; S H Wright; F Dufrayne; G Bergman
Journal:  Gastrointest Endosc       Date:  2000-09       Impact factor: 9.427

Review 9.  Systemic complications of acromegaly: epidemiology, pathogenesis, and management.

Authors:  Annamaria Colao; Diego Ferone; Paolo Marzullo; Gaetano Lombardi
Journal:  Endocr Rev       Date:  2004-02       Impact factor: 19.871

10.  Elevated circulating somatostatin levels in acromegaly.

Authors:  M Arosio; S Porretti; P Epaminonda; C Giavoli; C Gebbia; C Penati; P Beck-Peccoz; M Peracchi
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.